Reps. Alcee Hastings (D-FL) and Vern Buchanan (R-FL) reintroduced the Humane Research and Testing Act (H.R. 1744) to "amend the Public Health Service Act to provide for the establishment of the National Center for Alternatives to Animals in Research and Testing, and for other purposes." NABR is strongly encouraging members to use our take action tool to oppose this bill!
H.R. 1744 is identical to the Humane Research and Testing Act of 2020 (H.R. 8633), which NABR opposed, filed at the end of last Congress. This bill is being supported by the Citizens for Alternatives to Animal Research and Experimentation (CAARE), an animal rights organization that claims to be dedicated to educating "the public, media, legislators and scientists about strategies to reduce and replace animal research." CAARE has various campaigns targeting Quincy Bioscience, National Institutes of Health (NIH), the Food and Drug Administration (FDA), the United States Department of Agriculture (USDA), and the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), among others.
Representatives Hastings and Buchanan have both been animal rights advocates for many years. According to Humane Society Legislative Fund's (HSLF) scorecard, Reps. Hastings boasts a 100+ rating and Rep. Buchanan a 100 rating. "I don't agree [animal research is necessary]. And I think most people would side with me," Buchanan said during a Sunday Morning News broadcast on April 2, 2017.
Although the H.R. 1744 bill text is not yet available on Congress.gov, the Humane Research and Testing Act of 2020 bill text is available. This bill would create a new National Center for Alternatives to Animals in Research under the NIH, despite the fact that National Center for Advancing Translational Sciences (NCATS) already exists. The bills would also mandate more reporting to Congress on the types and numbers of animals involved in research. Most shocking is the following statement in the bill:
"There is widespread agreement among scientists and regulatory agencies that animal models are poor predictors of the human response, with over 90 percent of new candidate drugs never making it to market.
More than 30 percent of promising medications have failed in human clinical trials because they are found to be toxic despite promising pre-clinical studies in animal models. An additional 65 percent of candidate drugs that pass animal trials fail due to lack of efficacy."
This premise shows a fundamental lack of understanding in the scientific process by the congressional offices sponsoring these bills. Yet CAARE states these bills have the endorsement of the Jane Goodall Institute, Cruelty Free International, Vanda Pharmaceuticals, and Dr. Donald Ingber MD, Ph.D. More recently, Vanda Pharmaceuticals lost a legal dispute with FDA over what Vanda reported as "unnecessary animal research" in regard to FDA's request to show canine safety data for the drug tradipitant.
The American biomedical research community supports valid and effective animal alternatives. However, these bills appear to create a ready-made animal rights targeting lists through further mandatory reporting and are aimed at eliminating animal models rather than helping the research community validate truly effective alternatives.
NABR is encouraging members to reach out to their U.S. representatives to oppose this bill. Use our quick take-action link here: https://www.nabr.org/take-action/oppose-humane-research-and-testing-act-2021
The 2020 AALAS National Meeting is going totally virtual! The onsite meeting in Charlotte has been canceled.
Registration is now FREE to AALAS National members for the meeting. Nonmembers will have a $100 registration fee.
Register for the National Meeting
This is a unique opportunity for the entire AALAS community to experience the National Meeting. Be sure to register and encourage other members to do so.
On the virtual platform, educational sessions will be pre-recorded and offered on-demand from the start of the meeting in October through the end of the year.
The AALAS National Meeting Preliminary Program is now online. Please note that the virtual program is being finalized and content in the Preliminary Program is subject to change.
On behalf of Americans for Medical Progress:
Do you know a 10th or 11th grader who is fascinated by life science, interested in explaining it to others and loves to write? If so, we have the perfect summer program for them.
Curious SCIENCE Writers (cSw), is an innovative steAm initiative that trains high school communicators how to translate science for public audiences through the team efforts of student writers, editors, artists and social media coordinators. The program features a week-long writing boot camp in the DC/MD area followed by a month of story development under the remote guidance of a professional science communications mentor. At the conclusion of the program, each writer will have produced a fully researched, clear and compelling biomedical science story for a general audience. Final story editing and publishing will take place throughout the 2020-2021 academic year.
This two-minute video offers some insights from past graduates of the program. You can view the results of the cSw program on our blog and on Facebook. There is also program flyer containing additional information.
KEY DATES
We’re also looking for professional communicators to serve as mentors or guest speakers and scientists who are willing to be interviewed about their work
For more information or to apply, visit https://curioussciencewriters.org. For questions please email info@curioussciencewriters.org.
This program is hosted by Americans for Medical Progress.
The AALAS Foundation and AMP are seeking NCAB Members to help staff their booths at the three day US Science & Engineering Festival at the Walter E. Washington Convention Center in Washington, DC.
DATES NEEDED
PREREQUISITES
Volunteers must attend a training teleconference. Teleconferences will be held Tuesday, April 7th at 11:00 am EST and Wednesday, April 15th (time TBD). Details will be emailed out volunteers, and volunteers only need to attend one training session.
Sign Up to Volunteer Now!
On behalf of NABR and the NCAB AALAS Government Relations Committee
Biomedical Research Community: Click Here to Take Action Now!
As previously reported by NABR, the Virginia State Senate will be voting on a bill banning the breeding of research dogs and cats this coming Tuesday. The Virginia Senate Agriculture Committee needs to hear from you now. Even non-Virginia residents can use these take-action buttons to communicate with the committee.
We can expect the targeting of breeding at the state and local level to continue throughout 2020. While so far, the target of such language has been limited to dogs and cats, “companion species”, once on the books, such language could be easily amended to include additional species or prohibit the research from being performed altogether.
Whether or not your facility uses dogs or cats bred in Virginia, or dogs and cats at all, everyone working with animals in research should be concerned by this trend. Efforts to ban the breeding of research animals should not be tolerated because it affects the entire research community. If this legislation passes, it will undoubtedly serve as a template for efforts in other states and could dramatically impact public health, as well as the health of our pets and other animals. NABR encourages members to stay in close contact with their government affairs team.
A hearing on these bills is occurring Tuesday in the Virginia Senate Agriculture Committee. Please send the committee a respectful, but firm message today using the red take-action buttons. We hope you find
If you require NABR's assistance, please email info@nabr.org or call 202-857-0540.
NABR | 1100 Vermont Avenue, NW, Suite 1100 | Washington, DC 20005 | Tel 202.857.0540 | Fax 202.659.1902 | info@nabr.org
Read the NCAB AALAS Winter 2019 Newsletter.
The Power of Risk Assessment:Laboratory Safety and Security for Clinical, Public Health, Research and Animal Care
February 29 - March 4, 2020Westin Perimeter North Hotel - Atlanta, GA
Learn More | Download Brochure
Register for the Symposium
Presented By: Centers for Disease Control and Prevention (CDC), in partnership with the Eagleson Institute and the American Biological Safety Association (ABSA International).
Cosponsored By: American Association for Laboratory Animal Science (AALAS), the Association of Public Health Laboratories (APHL), American Society of Laboratory Animal Practitioners (ASLAP), the American College of Laboratory Animal Medicine (ACLAM), and the American Industrial Hygiene Association (AIHA).
Don’t miss your chance to hear from and meet with imaging experts, researchers and professionals from the Johns Hopkins University, University of Maryland, National Institutes of Health, Janelia (HHMI), AstraZeneca (formerly Medimmune), and many local biotech companies.
Learn about how these institutions are applying the latest imaging technologies in Immuno-Oncology, Infectious Disease, Neurology, Comparative Medicine, Clinical Studies and more.
Register at EventBrite
Please email Norman Peterson if you or someone on your team would be willing to present a poster. Anything from 2018/2019 is acceptable and appreciated.
If you are reading, you are also part of our marketing team, so please, help spread the word! The agenda and a flier are below.
If you have any questions please feel free to email Norman Peterson.
References to any persons, organizations, activities, products, services, websites, etc., do not constitute or imply the endorsement, recommendation, or favor of NCAB/AALAS or Council members acting on its behalf.
